Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    Home»Daily News»iGalen and Holista announce resolution with ATM Metabolics
    Daily News

    iGalen and Holista announce resolution with ATM Metabolics

    Marie JonesBy Marie JonesNovember 8, 2019Updated:November 11, 2019No Comments2 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Holista, a research-driven biotech company that develops natural ingredient and wellness products, and its distributor iGalen are pleased to announce that they have resolved their disputes with ATM Metabolics and its founder Dr. Joseph Ahrens, a two time Nobel prize nominee and discoverer of Emulin. As a result, they will no longer be carrying Emulin.

    If you would like to purchase the product in the future, please contact ATM at www.atmmetabolics.com. We wish ATM and Dr. Ahrens success in their future endeavours, and thank them for working with us to resolve the disputes.

    Holista CollTech (ASX:HCT) is a research-driven biotech company. Headquartered in Perth with operations in Malaysia, it is dedicated to delivering first-class natural ingredients and wellness products globally. Holista’s ingredients include low-GI baked products, reduced-sodium salts, low-fat fried foods and low calorie sugar. www.holistaco.com.

    iGalern markets a range of premium-quality nutritional supplements that are sold directly to Distributors and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Singapore, Mexico, Malaysia, and the Philippines. Visit www.igalen.com.

    About Holista CollTech Ltd

    Holista CollTech Ltd (“Holista”) is a research-driven biotech company, the result of a merger between Holista Biotech Sdn Bhd and CollTech Australia Ltd. Headquartered in Perth and with extensive operations in Malaysia, the company is dedicated to delivering first-class natural ingredients and wellness products globally. Holista is a leader in the research of herbs and ingredients for the making of healthier food.

    Listed on the Australian Securities Exchange (“ASX”), Holista researches, develops, manufactures and markets “health-style” products to address the unmet and evolving needs of natural medicine. Holista’s suite of ingredients, among other things, includes low-GI baked products, reduced-sodium salts, low-fat fried foods and low calories sugar without compromising taste, odour and mouthfeel. Holista remains the only company to produce sheep (ovine) collagen using patented extraction methods. For more information, please refer to http://www.holistaco.com

    Holista iGalen
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous Article27th HK International Optical Fair draws over 14,000 buyers
    Next Article KASIKORNBANK, a major financial institution in Thailand, starts to adopt Smart Code(TM), the JCB QR and barcode payment scheme

    Related Posts

    Australian Made puts Singaporean approval centre-stage of its new campaign launch

    October 27, 2026

    Micot Pharma Showcases First-in-Class, Brain-Penetrant TrkB Agonist MT200605 at World Stroke Congress, Building the Case for Global Partnerships and Commercialization

    October 27, 2026

    ASN 2026: HighTide Therapeutics Presents New HTD1801 Data Highlighting Therapeutic Potential in Chronic Kidney Disease

    October 23, 2026
    Add A Comment

    Comments are closed.

    Latest News

    • Formerra Adjusts Transportation Surcharge Amid Continued Freight and Logistics Pressures
    • Twin lighting fairs open with some 3,000 exhibitors showcasing global lighting solutions
    • 18th Hong Kong International Wine & Spirits Fair opens next week
    • Quant Group Validates Its Physical AI Foundation Model in a Working Restaurant Kitchen
    • Australian Made puts Singaporean approval centre-stage of its new campaign launch
    • Micot Pharma Showcases First-in-Class, Brain-Penetrant TrkB Agonist MT200605 at World Stroke Congress, Building the Case for Global Partnerships and Commercialization
    • Quant Group (02685.HK) Enters into Framework Procurement Agreement for Up to 2,000 Embodied-AI Robots Solutions – Physical AI Business Poised for Re-rating
    • Chervon names Joel Petersheim as Vice President, End User Research and Sales – OPE Commercial USA
    • Chervon Names Parker Wesley Clary Director of Field Sales – Southern Division
    • Chervon Names Maggie Jones Director of National Field Sales OPS
    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.